![](../../files/images/goods/1309793-47-2.png)
CPSI-1306
CAS No. 1309793-47-2
CPSI-1306 ( cpsi-1306 | 2-(3-(2,4-Difluorophenyl)-4,5-dihydroisoxazol-5-yl)-1-morpholinoethan-1-one )
产品货号. M26869 CAS No. 1309793-47-2
(±)-CPSI-1306 是一种巨噬细胞迁移抑制因子 (MIF) 拮抗剂,可用于非胰岛素依赖型糖尿病 (NIDDM) 的研究以及预防急性和慢性 UVB 暴露对皮肤的有害影响。
纯度: >98% (HPLC)
![](/themes/theme/en/images/pdf.png)
![](/themes/theme/en/images/pdf.png)
![](/themes/theme/en/images/pdf.png)
![](/themes/theme/en/images/pdf.png)
![](/themes/theme/en/images/pdf.png)
![](/themes/theme/en/images/pdf.png)
规格 | 价格/人民币 | 库存 | 数量 |
10MG | ¥365 | 有现货 |
![]() ![]() |
25MG | ¥664 | 有现货 |
![]() ![]() |
50MG | ¥1199 | 有现货 |
![]() ![]() |
100MG | ¥2171 | 有现货 |
![]() ![]() |
200MG | ¥2957 | 有现货 |
![]() ![]() |
500MG | 获取报价 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称CPSI-1306
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述(±)-CPSI-1306 是一种巨噬细胞迁移抑制因子 (MIF) 拮抗剂,可用于非胰岛素依赖型糖尿病 (NIDDM) 的研究以及预防急性和慢性 UVB 暴露对皮肤的有害影响。
-
产品描述(±)-CPSI-1306 is a macrophage migration inhibitory factor (MIF) antagonist and can be used in studies about non-insulin-dependent diabetes mellitus (NIDDM) and the prevention of the deleterious cutaneous effects of acute and chronic UVB exposure.(In Vivo):In mice, (±)-CPSI-1306 decreases their blood glucose levels and can be effective in treating non-insulin-dependent diabetes mellitus (NIDDM) as characterized by high serum levels of glucose and inflammatory cytokine. (±)-CPSI-1306-induced keratinocyte apoptosis is appreciated 30 minutes after a single UVB exposure. (±)-CPSI-1306-treated mice show a significant increase in expression of cleaved caspase-3 at 6, 24, and 48 hours following UVB exposure. (±)-CPSI-1306 reduces acute UVB-induced keratinocyte DNA damage and UVB-induced acute inflammation.
-
体外实验——
-
体内实验Mice treated with CPSI-1306 show a significant drop in their blood glucose levels, which is associated with a reduction in serum levels of inflammatory cytokines. As expected, control mice treated with vehicle develop NIDDM as characterized by high serum levels of glucose and inflammatory cytokine. Furthermore, they also show that orally bioavailable CPSI-1306 can be effective in treating this disease. CPSI-1306-induced keratinocyte apoptosis could be appreciated as early as 30 minutes after a single UVB exposure. At 6, 24, and 48 hours following UVB exposure, the CPSI-1306-treated mice show significantly increased expression of cleaved caspase-3 compared with the vehicle-treated mice. CPSI-1306 reduces acute UVB-induced keratinocyte DNA damage and UVB-induced acute inflammation.
-
同义词cpsi-1306 | 2-(3-(2,4-Difluorophenyl)-4,5-dihydroisoxazol-5-yl)-1-morpholinoethan-1-one
-
通路Others
-
靶点Other Targets
-
受体AddAB helicase-nuclease| RecBCD helicase-nuclease
-
研究领域——
-
适应症——
化学信息
-
CAS Number1309793-47-2
-
分子量310.301
-
分子式C15H16F2N2O3
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO : 6 mg/mL (19.34 mM)
-
SMILESFc1ccc(C2=NOC(CC(=O)N3CCOCC3)C2)c(F)c1
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Bannister TD, et al. ML328: A Novel Dual Inhibitor of Bacterial AddAB and RecBCD Helicase-nuclease DNA Repair Enzymes. 2012 Dec 17 [updated 2013 Apr 5]. In: Probe Reports from the NIH Molecular Libraries Program [Internet].
产品手册
![](/themes/theme/en/images/ct.png)
![](/themes/theme/en/images/new12.jpg)
![](/themes/theme/en/images/gift.jpg)
![](/themes/theme/en/images/ct2.png)
关联产品
-
(-)-Syringaresinol
(-)-丁香脂素源自蒙大拿番荔枝的茎。 (-)-Syringaresinol 通过 G1 期阻滞和诱导细胞凋亡来抑制人早幼粒细胞 HL-60 细胞的增殖,并具有抗癌活性。
-
4-Bromo-2-(2,6-dioxo...
4-Bromo-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione 是一种化合物。
-
LY392098
LY392098 是 AMPA 受体的增强剂。